TKUNF (Tikun Olam Cannbit Pharmaceuticals) Total Assets: $0.50 Mil (As of Dec. 2025)


TKUNF Tikun Olam Cannbit Pharmaceuticals Ltd TKUNF
16 GF Score
Price $6.00
GF Value $4.73
! 6 Warning Signs
View Full Analysis

What is Tikun Olam Cannbit Pharmaceuticals Total Assets?

Tikun Olam Cannbit Pharmaceuticals TKUNF 16 Total Assets is $0.50 Mil as of Dec. 2025. GuruFocus rates TKUNF with a GF Score™ of 16/100 and a GF Value™ of $4.73. The stock has 6 warning signs investors should review.

Tikun Olam Cannbit Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2025 was $0.50 Mil.

During the past 12 months, Tikun Olam Cannbit Pharmaceuticals's average Total Assets Growth Rate was -93.80% per year. During the past 3 years, the average Total Assets Growth Rate was -48.70% per year. During the past 5 years, the average Total Assets Growth Rate was -29.70% per year. During the past 10 years, the average Total Assets Growth Rate was 58.80% per year.

During the past 13 years, Tikun Olam Cannbit Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 2069.40%. The lowest was -84.70%. And the median was -5.65%.

Total Assets is connected with ROA %. Tikun Olam Cannbit Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2025 was -61.42%. Total Assets is also linked to Revenue through Asset Turnover. Tikun Olam Cannbit Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2025 was 0.12.

Tikun Olam Cannbit Pharmaceuticals  (OTCPK:TKUNF) Total Assets Explanation

Total Assets is connected with ROA %.

Tikun Olam Cannbit Pharmaceuticals's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-0.956/( (2.613+0.5)/ 2 )
=-0.956/1.5565
=-61.42 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tikun Olam Cannbit Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.19/( (2.613+0.5)/ 2 )
=0.19/1.5565
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tikun Olam Cannbit Pharmaceuticals Total Assets Related Terms

Tikun Olam Cannbit Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Tikun Olam Cannbit Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tikun Olam Cannbit Pharmaceuticals Total Assets Chart

Tikun Olam Cannbit Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.97 63.29 52.30 25.54 8.01

Tikun Olam Cannbit Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.54 14.24 8.01 2.61 0.50
TKUNF
16GF Score
Tikun Olam Cannbit Pharmaceuticals Ltd TKUNF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tikun Olam Cannbit Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tikun Olam Cannbit Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=-1.783+9.789
=8.01

Tikun Olam Cannbit Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=-6.991+7.491
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.50 Mil mean?
Tikun Olam Cannbit Pharmaceuticals (TKUNF) has a Total Assets of $0.50 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Tikun Olam Cannbit Pharmaceuticals and its competitors.
Is Tikun Olam Cannbit Pharmaceuticals' Total Assets too high?
Tikun Olam Cannbit Pharmaceuticals' current Total Assets is $0.50 Mil. Overall, Tikun Olam Cannbit Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Tikun Olam Cannbit Pharmaceuticals' Total Assets compare to ZTS and UTHR?
Tikun Olam Cannbit Pharmaceuticals' Total Assets of $0.50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Tikun Olam Cannbit Pharmaceuticals and its competitors. Tikun Olam Cannbit Pharmaceuticals's current Total Assets is $0.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tikun Olam Cannbit Pharmaceuticals stock overvalued right now?
Tikun Olam Cannbit Pharmaceuticals (TKUNF) has a current Total Assets of $0.50 Mil. The stock's GF Value™ is $4.73, compared to a current price of $6.00 — trading 26.8% above its estimated fair value. The current Total Assets is $0.50 Mil. Tikun Olam Cannbit Pharmaceuticals' overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Tikun Olam Cannbit Pharmaceuticals (TKUNF), the current Total Assets is $0.50 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tikun Olam Cannbit Pharmaceuticals (TKUNF) Overvalued in 2026?

Based on GuruFocus' analysis, Tikun Olam Cannbit Pharmaceuticals stock appears to be overvalued. The current stock price of $6.00 is trading 26.8% above its estimated GF Value™ of $4.73.

Key valuation signals for TKUNF:

  • Total Assets: $0.50 Mil
  • GF Value™: $4.73 vs. price of $6.00 (26.8% above fair value)
  • GF Score™: 16/100 with 6 warning signs

No single metric tells the full story. See the TKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tikun Olam Cannbit Pharmaceuticals Business Description

Other Exchanges TKUN:Israel
Address The Fourteenth, Tel Aviv, ISR
Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.
16GF Score

Get the complete analysis for TKUNF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$4.73
GF Value